Breaking News Instant updates and real-time market news.

2020-05-04 05:35:41 BBDC Barings BDC $6.61 / -0.14 (-2.07%) 05:35 05/04/20 05/04 05:35 05/04/20 05:35	Barings BDC upgraded to Buy from Neutral at Compass Point Compass Point analyst Casey Alexander upgraded Barings BDC to Buy from Neutral with an $8.50 price target.
BBDC Barings BDC $6.61 / -0.14 (-2.07%) 04/02/20 Compass Point Barings BDC downgraded to Neutral from Buy at Compass Point 03/17/20 National Securities Barings BDC upgraded to Buy from Neutral at National Securities 10/23/19 National Securities Barings BDC initiated with a Neutral at National Securities

2020-05-04 05:35:41

BBDC

Barings BDC

$6.61 / -0.14 (-2.07%)

05:35

05/04/20

05/04

05:35

05/04/20

05:35

Barings BDC upgraded to Buy from Neutral at Compass Point

Compass Point analyst Casey Alexander upgraded Barings BDC to Buy from Neutral with an $8.50 price target.

BBDC Barings BDC

$6.61 / -0.14 (-2.07%)

04/02/20 Compass Point: Barings BDC downgraded to Neutral from Buy at Compass Point

03/17/20 National Securities: Barings BDC upgraded to Buy from Neutral at National Securities

10/23/19 National Securities: Barings BDC initiated with a Neutral at National Securities

TODAY'S FREE FLY STORIES

Options	KE Holdings put volume heavy and directionally bearish » 15:15 04/14/21 04/14 15:15 04/14/21 15:15 BEKE KE Holdings $49.90 / -3.69 (-6.89%) Bearish flow noted in KE… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Options BEKE KE Holdings $49.90 / -3.69 (-6.89%) 03/16/21 KE Holdings rises 20.8% 03/16/21 KE Holdings rises 12.7% 03/16/21 KE Holdings rises 8.1% 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal BEKE KE Holdings $49.90 / -3.69 (-6.89%) 04/07/21 Credit Suisse KE Holdings initiated with an Outperform at Credit Suisse 03/18/21 BofA KE Holdings upgraded to Buy from Neutral at BofA 03/18/21 BofA KE Holdings upgraded to Buy from Neutral at BofA 03/11/21 Goldman Sachs KE Holdings upgraded to Buy from Neutral at Goldman Sachs BEKE KE Holdings $49.90 / -3.69 (-6.89%) 03/15/21 KE Holdings sees Q1 revenue $2.8B-$3B, consensus $2.11B 03/15/21 KE Holdings reports Q4 adjusted EPS 26c, consensus 14c 11/16/20 KE Holdings sees Q4 revenue $2.8B-$3B, consensus $2.82B 11/16/20 KE Holdings reports Q3 adjusted income per ADS 20c, consensus 17c. 19 Nov 13 Aug BEKE KE Holdings $49.90 / -3.69 (-6.89%) 04/12/21 KE Holdings put volume heavy and directionally bearish 03/24/21 KE Holdings put volume heavy and directionally bearish 01/26/21 KE Holdings put volume heavy and directionally bearish 12/07/20 KE Holdings put volume heavy and directionally bearish
Recommendations	ASM International price target raised to EUR 295 from EUR 250 at Barclays » 15:14 04/14/21 04/14 15:14 04/14/21 15:14 ASMIY ASM International $321.49 / +6.49 (+2.06%) Barclays analyst Keegan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Events ASMIY ASM International $321.49 / +6.49 (+2.06%) 03/30/21 Morgan Stanley ASM International price target raised to EUR 240 from EUR 154 at Morgan Stanley 03/02/21 Deutsche Bank ASM International price target raised to EUR 250 from EUR 210 at Deutsche Bank 03/01/21 Barclays ASM International price target raised to EUR 250 from EUR 210 at Barclays 03/01/21 Credit Suisse ASM International price target raised to EUR 265 from EUR 250 at Credit Suisse 04/21/21 ASM International - ASMIY
Recommendations	Aixtron price target raised to EUR 24 from EUR 23 at Barclays » 15:14 04/14/21 04/14 15:14 04/14/21 15:14 AIXXF Aixtron $22.70 / + (+0.00%) Barclays analyst Andrew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research AIXXF Aixtron $22.70 / + (+0.00%) 03/09/21 Berenberg Aixtron price target raised to EUR 18 from EUR 11 at Berenberg 02/26/21 Barclays Aixtron price target raised to EUR 23 from EUR 15.50 at Barclays 02/19/21 Deutsche Bank Aixtron price target raised to EUR 22 from EUR 14 at Deutsche Bank 01/14/21 Barclays Aixtron price target raised to EUR 15.50 from EUR 13 at Barclays
Recommendations	LVMH price target raised to EUR 635 from EUR 600 at RBC Capital » 15:11 04/14/21 04/14 15:11 04/14/21 15:11 LVMUY LVMH $147.85 / +6.86 (+4.87%) RBC Capital analyst Piral… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly LVMUY LVMH $147.85 / +6.86 (+4.87%) 04/13/21 LVMH says 'well-equipped to build upon the hoped-for recovery' 02/22/21 LVMH's Moet Hennessy takes 50% stake in Jay-Z's Armand de Brignac brand 12/31/20 Tiffany holders approve LVMH takeover, deal to close on January 7 10/29/20 LVMH, Tiffany agree to reduced takeover price of $131.50 per share LVMUY LVMH $147.85 / +6.86 (+4.87%) 15:08 Today JPMorgan LVMH price target raised to EUR 685 from EUR 625 at JPMorgan 10:46 Today Societe Generale LVMH price target raised to EUR 690 from EUR 615 at Societe Generale 04/07/21 Deutsche Bank LVMH price target raised to EUR 495 from EUR 440 at Deutsche Bank 03/30/21 UBS LVMH price target raised to EUR 640 from EUR 623 at UBS LVMUY LVMH $147.85 / +6.86 (+4.87%) 04/13/21 LVMH reports Q1 revenue EUR 13.96B, consensus EUR 12.7B 10/15/20 LVMH reports Q3 revenue EUR 11.96B vs. EUR 13.32B last year 10/15/20 LVMH reports Q3 organic revenue down 7% LVMUY LVMH $147.85 / +6.86 (+4.87%) 02/10/21 Rihanna's Fenty fashion line put on hold, WWD reports 10/28/20 LVMH, Tiffany near deal to lower takeout price to $131.50 from $135, WSJ says 10/27/20 Tiffany seeks around $132 per share from LVMH, Bloomberg reports 10/27/20 Tiffany close to new deal price of $130-$133 per share from LVMH, CNBC says LVMUY LVMH $147.85 / +6.86 (+4.87%) 10/27/20 Fly Intel: Wall Street's top stories for Tuesday
Recommendations	Henkel price target raised to EUR 111 from EUR 104 at RBC Capital » 15:11 04/14/21 04/14 15:11 04/14/21 15:11 HENKY Henkel $25.39 / +0.1 (+0.40%) RBC Capital analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research HENKY Henkel $25.39 / +0.1 (+0.40%) 15:08 Today JPMorgan Henkel price target raised to EUR 120 from EUR 115 at JPMorgan 04/06/21 Barclays Henkel price target raised to EUR 106 from EUR 94 at Barclays 04/01/21 UBS Henkel price target raised to EUR 93 from EUR 88 at UBS 03/22/21 JPMorgan Henkel price target raised to EUR 115 from EUR 100 at JPMorgan

Recommendations	Just Eat Takeaway.com price target lowered to 11,423 GBp at JPMorgan » 15:10 04/14/21 04/14 15:10 04/14/21 15:10 TKAYY Just Eat Takeaway.com $10.80 / +0.52 (+5.06%) JPMorgan analyst Marcus… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals TKAYY Just Eat Takeaway.com $10.80 / +0.52 (+5.06%) 04/07/21 Morgan Stanley Just Eat price target raised to 11,400 GBp from 11,100 GBp at Morgan Stanley 03/11/21 Barclays Just Eat Takeaway.com price target raised to 12,080 GBp from 11,990 GBp at Barclays 03/04/21 UBS Just Eat Takeaway.com price target raised to 9,800 GBp from 9,700 GBp at UBS 03/04/21 Morgan Stanley Just Eat Takeaway.com price target lowered to 11,100 GBp at Morgan Stanley TKAYY Just Eat Takeaway.com $10.80 / +0.52 (+5.06%) 03/22/21 Deliveroo targets $12B in London IPO, WSJ reports
Recommendations	VAT Group price target raised to CHF 260 from CHF 165 at JPMorgan » 15:09 04/14/21 04/14 15:09 04/14/21 15:09 VACNY VAT Group $31.05 / + (+0.00%) JPMorgan analyst Sandeep… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research VACNY VAT Group $31.05 / + (+0.00%) 04/09/21 UBS VAT Group price target raised to CHF 300 from CHF 280 at UBS 01/12/21 Deutsche Bank VAT Group price target raised to CHF 225 from CHF 175 at Deutsche Bank 01/12/21 UBS VAT Group price target raised to CHF 255 from CHF 207 at UBS 11/24/20 UBS VAT Group price target raised to CHF 207 from CHF 190 at UBS
Recommendations	Tele2 price target raised to SEK 147 from SEK 145 at JPMorgan » 15:09 04/14/21 04/14 15:09 04/14/21 15:09 TLTZY Tele2 $6.96 / + (+0.00%) JPMorgan analyst Roman… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TLTZY Tele2 $6.96 / + (+0.00%) 03/09/21 JPMorgan Tele2 price target lowered to SEK 145 from SEK 160 at JPMorgan 02/23/21 Morgan Stanley Tele2 downgraded to Equal Weight from Overweight at Morgan Stanley 02/03/21 Barclays Tele2 price target lowered to SEK 125 from SEK 130 at Barclays 12/16/20 Deutsche Bank Tele2 price target raised to SEK 122 from SEK 117 at Deutsche Bank
Recommendations	LVMH price target raised to EUR 685 from EUR 625 at JPMorgan » 15:08 04/14/21 04/14 15:08 04/14/21 15:08 LVMUY LVMH $147.85 / +6.86 (+4.87%) JPMorgan analyst Chiara… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly LVMUY LVMH $147.85 / +6.86 (+4.87%) 04/13/21 LVMH says 'well-equipped to build upon the hoped-for recovery' 02/22/21 LVMH's Moet Hennessy takes 50% stake in Jay-Z's Armand de Brignac brand 12/31/20 Tiffany holders approve LVMH takeover, deal to close on January 7 10/29/20 LVMH, Tiffany agree to reduced takeover price of $131.50 per share LVMUY LVMH $147.85 / +6.86 (+4.87%) 10:46 Today Societe Generale LVMH price target raised to EUR 690 from EUR 615 at Societe Generale 04/07/21 Deutsche Bank LVMH price target raised to EUR 495 from EUR 440 at Deutsche Bank 03/30/21 UBS LVMH price target raised to EUR 640 from EUR 623 at UBS 03/29/21 Morgan Stanley LVMH price target raised to EUR 625 from EUR 600 at Morgan Stanley LVMUY LVMH $147.85 / +6.86 (+4.87%) 04/13/21 LVMH reports Q1 revenue EUR 13.96B, consensus EUR 12.7B 10/15/20 LVMH reports Q3 revenue EUR 11.96B vs. EUR 13.32B last year 10/15/20 LVMH reports Q3 organic revenue down 7% LVMUY LVMH $147.85 / +6.86 (+4.87%) 02/10/21 Rihanna's Fenty fashion line put on hold, WWD reports 10/28/20 LVMH, Tiffany near deal to lower takeout price to $131.50 from $135, WSJ says 10/27/20 Tiffany seeks around $132 per share from LVMH, Bloomberg reports 10/27/20 Tiffany close to new deal price of $130-$133 per share from LVMH, CNBC says LVMUY LVMH $147.85 / +6.86 (+4.87%) 10/27/20 Fly Intel: Wall Street's top stories for Tuesday
Recommendations	Henkel price target raised to EUR 120 from EUR 115 at JPMorgan » 15:08 04/14/21 04/14 15:08 04/14/21 15:08 HENKY Henkel $25.39 / +0.1 (+0.40%) JPMorgan analyst Celine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HENKY Henkel $25.39 / +0.1 (+0.40%) 04/06/21 Barclays Henkel price target raised to EUR 106 from EUR 94 at Barclays 04/01/21 UBS Henkel price target raised to EUR 93 from EUR 88 at UBS 03/22/21 JPMorgan Henkel price target raised to EUR 115 from EUR 100 at JPMorgan 03/19/21 Bernstein Henkel upgraded to Market Perform from Underperform at Bernstein

Recommendations	Evonik price target raised to EUR 32 from EUR 28.50 at JPMorgan » 15:07 04/14/21 04/14 15:07 04/14/21 15:07 EVKIF Evonik $35.92 / + (+0.00%) JPMorgan analyst Chetan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research EVKIF Evonik $35.92 / + (+0.00%) 12/07/20 Durect to sell Lactel product line to Evonik for $15M EVKIF Evonik $35.92 / + (+0.00%) 04/07/21 Societe Generale Evonik price target raised to EUR 36 from EUR 30 at Societe Generale 03/25/21 Morgan Stanley Evonik price target raised to EUR 35 from EUR 30 at Morgan Stanley 03/09/21 DZ Bank Evonik downgraded to Hold from Buy at DZ Bank 03/08/21 Berenberg Evonik price target raised to EUR 31 from EUR 26 at Berenberg
Recommendations	Buzzi Unicem price target raised to EUR 25 from EUR 24 at JPMorgan » 15:07 04/14/21 04/14 15:07 04/14/21 15:07 BZZUY Buzzi Unicem $13.39 / + (+0.00%) JPMorgan analyst Elodie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BZZUY Buzzi Unicem $13.39 / + (+0.00%) 04:47 Today Berenberg Buzzi Unicem initiated with a Buy at Berenberg 03/30/21 Morgan Stanley Buzzi Unicem price target lowered to EUR 22.40 from EUR 22.90 at Morgan Stanley 03/29/21 Barclays Buzzi Unicem price target lowered to EUR 24 from EUR 25 at Barclays 02/26/21 JPMorgan Buzzi Unicem price target raised to EUR 24 from EUR 23 at JPMorgan
Earnings	LCI Industries sees Q1 revenue $1.0B,consensus $880.28M » 15:06 04/14/21 04/14 15:06 04/14/21 15:06 LCII LCI Industries $139.60 / +2.77 (+2.02%) LCI Industrie provided… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events LCII LCI Industries $139.60 / +2.77 (+2.02%) 14:28 Today LCI Industries trading halted, news pending 02/25/21 Lippert promotes Eileen Pruitt to Deputy CHRO, Senior Legal Counsel 12/22/20 LCI Industries CEO sells 10,000 common shares LCII LCI Industries $139.60 / +2.77 (+2.02%) 09/25/20 Northcoast LCI Industries upgraded to Buy from Neutral at Northcoast 09/22/20 CJS Securities LCI Industries upgraded to Outperform from Market Perform at CJS Securities 07/15/20 CL King LCI Industries price target raised to $134 from $121 at CL King 07/06/20 Citi LCI Industries initiated with a Neutral at Citi LCII LCI Industries $139.60 / +2.77 (+2.02%) 02/09/21 LCI Industries reports Q4 EPS $1.92, consensus $1.79 11/02/20 LCI Industries reports Q3 adj. EPS $2.72, consensus $2.42 LCII LCI Industries $139.60 / +2.77 (+2.02%) 02/03/21 Fly Intel: After-Hours Movers 05/20/21 LCI Industries
Recommendations	Infosys stock reaction may reflect valuation/sentiment into report, says Stifel » 15:04 04/14/21 04/14 15:04 04/14/21 15:04 INFY Infosys $17.37 / -1.04 (-5.65%) Stifel analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options INFY Infosys $17.37 / -1.04 (-5.65%) 10:00 Today Infosys falls -4.8% 07:24 Today Infosys board recommends capital return of $2.08B, including dividend, buyback 04/08/21 Infosys announces collaboration with ArcelorMittal 03/31/21 Infosys, LivePerson announce AI-powered conversation partnership INFY Infosys $17.37 / -1.04 (-5.65%) 07:05 Today Baird Infosys price target raised to $18 from $17 at Baird 03/24/21 Bernstein Infosys upgraded to Outperform as multi-year cloud winner at Bernstein 03/23/21 Bernstein Infosys upgraded to Outperform from Market Perform at Bernstein 01/14/21 Investec Infosys downgraded to Hold from Buy at Investec INFY Infosys $17.37 / -1.04 (-5.65%) 07:23 Today Infosys sees FY22 revenue growth 12%-14% in constant currency 07:23 Today Infosys reports Q4 basic EPS 16c, consensus 16c 01/13/21 Infosys boosts FY21 revenue growth view to 4.5%-5% in constant currency 01/13/21 Infosys reports Q3 basic EPS 17c, consensus 15c INFY Infosys $17.37 / -1.04 (-5.65%) 03/03/21 Infosys wins $500M all-digital deal from Google, The Economic Times says INFY Infosys $17.37 / -1.04 (-5.65%) 08:59 Today Fly Intel: Pre-market Movers 08:30 Today Infosys - INFY INFY Infosys $17.37 / -1.04 (-5.65%) 03/04/21 Unusually active option classes on open March 4th 03/03/21 Infosysy calls see heavy early volume 10/27/20 Largest borrow rate increases among liquid names
Options	NeuroBo Pharmaceuticals options imply 29.7% move in share price post-earnings » 15:04 04/14/21 04/14 15:04 04/14/21 15:04 NRBO NeuroBo Pharmaceuticals $3.75 / + (+0.00%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options NRBO NeuroBo Pharmaceuticals $3.75 / + (+0.00%) 03/24/21 NeuroBo Pharma's contingent value rights amendment for Gemcabene approved 01/06/21 NeuroBo Pharmaceuticals acquires ANA Therapeutics NRBO NeuroBo Pharmaceuticals $3.75 / + (+0.00%) 02/01/21 H.C. Wainwright NeuroBo Pharmaceuticals price target lowered to $16 from $20 at H.C. Wainwright 06/15/20 H.C. Wainwright NeuroBo Pharmaceuticals initiated with a Buy at H.C. Wainwright NRBO NeuroBo Pharmaceuticals $3.75 / + (+0.00%) 02/03/21 new option listings on February 3rd

Hot Stocks	Capcom officially closes investigation into November 2020 ransomware attack » 15:01 04/14/21 04/14 15:01 04/14/21 15:01 CCOEY Capcom $17.01 / -0.08 (-0.47%) Capcom said that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly CCOEY Capcom $17.01 / -0.08 (-0.47%) 03/12/21 'Super Mario 3D World + Bowser's Fury' best-selling game of February, says NPD 01/20/21 EU fines Valve, Capcom, ZeniMax, others EUR7.8M for 'geo-blocking' practices 01/15/21 Activision's 'COD: Black Ops: Cold War' best-selling game of 2020, says NPD 01/06/21 Digital video game sales rose 12% y/y to $126.6B in 2020, says SuperData CCOEY Capcom $17.01 / -0.08 (-0.47%) 06/09/20 JPMorgan Capcom upgraded to Overweight from Neutral at JPMorgan CCOEY Capcom $17.01 / -0.08 (-0.47%) 02/26/21 Capcom says 'Monster Hunter Rise' will be on PC in 2022, IGN says CCOEY Capcom $17.01 / -0.08 (-0.47%) 03/23/21 Game On: Microsoft in talks to buy Discord as Sony acquires EVO 01/26/21 Game On: GameStop continues puzzling surge 11/17/20 Game On: NPD says total U.S. game industry spending continues to break records
Conference/Events	Protara Therapeutics management to meet virtually with Oppenheimer » 15:01 04/14/21 04/14 15:01 04/14/21 15:01 TARA Protara Therapeutics $16.95 / +0.27 (+1.62%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events TARA Protara Therapeutics $16.95 / +0.27 (+1.62%) 02/02/21 Protara Therapeutics reports inducement grants under Nasdaq listing rule 02/02/21 Protara Therapeutics appoints Cynthia Smith to board of directors 12/07/20 Protara Therapeutics names Jacqueline Zummo Chief Scientific Operations Officer 12/03/20 Protara Therapeutics reports inducement grants under Nasdaq listing rule TARA Protara Therapeutics $16.95 / +0.27 (+1.62%) 10/19/20 Cowen Protara Therapeutics initiated with an Outperform at Cowen 07/29/20 Fly Intel: Top five analyst initiations 07/29/20 Guggenheim Protara Therapeutics started with Buy rating, $50 target at Guggenheim 07/29/20 Guggenheim Protara Therapeutics initiated with a Buy at Guggenheim TARA Protara Therapeutics $16.95 / +0.27 (+1.62%) 03/11/21 Protara Therapeutics reports Q4 EPS (79c), consensus (54c) 11/12/20 Protara Therapeutics reports Q3 EPS ($1.26), two est. (62c) 22 Sep 04/21/21 FuboTV 04/22/21 Protara Therapeutics
Conference/Events	Paychex management to meet virtually with Oppenheimer » 14:59 04/14/21 04/14 14:59 04/14/21 14:59 PAYX Paychex $96.90 / +0.59 (+0.61%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PAYX Paychex $96.90 / +0.59 (+0.61%) 04/07/21 Paychex CEO: Net client gain was best in four years in Q3 04/06/21 Paychex sees FY22 effective tax rate 24%-25% 04/06/21 Paychex sees FY22 adjusted operating margin approximately 37% 04/06/21 Paychex sees FY22 total service revenue growth 6%-7% PAYX Paychex $96.90 / +0.59 (+0.61%) 04/07/21 Baird Paychex price target raised to $94 from $82 at Baird 04/07/21 Argus Paychex price target raised to $105 from $103 at Argus 04/07/21 BMO Capital Paychex price target raised to $96 from $93 at BMO Capital 04/07/21 Goldman Sachs Goldman boosts Paychex target, keeps Sell rating on valuation PAYX Paychex $96.90 / +0.59 (+0.61%) 04/06/21 Paychex raises FY21 adjusted EPS view to flat to down 2% from down 1%-4% 04/06/21 Paychex reports Q3 adjusted EPS 96c, consensus 92c 04/05/21 Notable companies reporting before tomorrow's open 04/05/21 Notable companies reporting before tomorrow's open PAYX Paychex $96.90 / +0.59 (+0.61%) 04/06/21 Fly Intel: Pre-market Movers 12/24/20 Fiserv, FuboTV initiations among today's top calls on Wall Street 04/21/21 Paychex
Conference/Events	Inovio management to meet virtually with Oppenheimer » 14:58 04/14/21 04/14 14:58 04/14/21 14:58 INO Inovio $8.97 / +0.235 (+2.69%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options INO Inovio $8.97 / +0.235 (+2.69%) 03/01/21 Inovio reports REVEAL 1 trial met primary, secondary endpoints 02/24/21 Qiagen, Inovio expand collaboration to develop NGS companion diagnostic 02/23/21 Inovio doses first patient in Phase 1B clinical trial for INO-4500 01/06/21 Inovio reports positive efficacy results from Phase 2 trial of VGX-3100 INO Inovio $8.97 / +0.235 (+2.69%) 03/23/21 Fly Intel: Top five analyst initiations 03/23/21 BofA Inovio initiated with a Neutral at BofA 03/02/21 Piper Sandler Piper lowers Inovio target to $7 after 'decidedly negative' update 02/11/21 Oppenheimer Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target INO Inovio $8.97 / +0.235 (+2.69%) 03/01/21 Inovio reports Q4 EPS (14c), consensus (22c) 11/09/20 Inovio reports Q3 EPS 11c, consensus (19c) 21 Jan INO Inovio $8.97 / +0.235 (+2.69%) 03/01/21 Fly Intel: After-Hours Movers 02/12/21 Initiation of 'disrupter' Inovio among today's top calls on Wall Street 02/12/21 Fly Intel: Pre-market Movers 01/21/21 Fly Intel: Pre-market Movers 04/16/21 FuboTV 05/13/21 Inovio Pharmaceuticals, Inc INO Inovio $8.97 / +0.235 (+2.69%) 03/01/21 Inovio options imply 19.7% move in share price post-earnings 02/23/21 Inovio put volume heavy and directionally bearish 02/12/21 Unusually active option classes on open February 12th 02/01/21 Inovio call volume above normal and directionally bullish
Conference/Events	Homology Medicines management to meet virtually with Oppenheimer » 14:57 04/14/21 04/14 14:57 04/14/21 14:57 FIXX Homology Medicines $7.24 / +0.07 (+0.98%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events FIXX Homology Medicines $7.24 / +0.07 (+0.98%) 08:40 Today Homology Medicines announces two presentations on phenylketonuria, MPS II 04/12/21 Homology Medicines announces promotion of Tim Kelly to COO 04/12/21 Homology Medicines announces promotion of Tim Kelly to COO 04/06/21 Homology Medicines drops 8% to $8.51 after announcing $50M stock offering FIXX Homology Medicines $7.24 / +0.07 (+0.98%) 03/01/21 Stifel Homology Medicines initiated with a Hold at Stifel 03/01/21 Oppenheimer Homology Medicines loses potential source of upside, says Oppenheimer 12/14/20 H.C. Wainwright Homology Medicines transferred with Buy, $30 target at H.C. Wainwright 11/08/20 Oppenheimer Homology Medicines selloff unjustified in wake of clinical PoC, says Oppenheimer FIXX Homology Medicines $7.24 / +0.07 (+0.98%) 03/11/21 Homology Medicines reports Q4 EPS (62c), consensus (68c) 11/09/20 Homology Medicines reports Q 3EPS (62c), consensus (80c) 07 Apr FIXX Homology Medicines $7.24 / +0.07 (+0.98%) 04/07/21 Fly Intel: Pre-market Movers 04/06/21 Fly Intel: After-Hours Movers 11/19/20 Fly Intel: After-Hours Movers 04/15/21 FuboTV

Conference/Events	Deere management to meet virtually with Oppenheimer » 14:57 04/14/21 04/14 14:57 04/14/21 14:57 DE Deere $381.47 / +2.69 (+0.71%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options DE Deere $381.47 / +2.69 (+0.71%) 02/24/21 Deere board increases quarterly dividend 18% to 90c 02/19/21 Deere: Supplies of key components and parts remain tight 02/19/21 Deere committed to improving diversity at company 02/19/21 Deere: Large tractor order book now extends into Q4 DE Deere $381.47 / +2.69 (+0.71%) 04/13/21 Deutsche Bank Deere price target raised to $402 from $360 at Deutsche Bank 04/12/21 Wolfe Research Deere initiated with an Outperform at Wolfe Research 03/16/21 Citi Deere price target raised to $400 from $375 at Citi 03/04/21 Citi Deere price target raised to $375 from $325 at Citi DE Deere $381.47 / +2.69 (+0.71%) 02/19/21 Deere sees FY21 Production & Precision Agriculture revenue up 1% 02/19/21 Deere raises FY21 earnings outlook to $4.6B-$5B from $3.6B-$4B 02/19/21 Deere reports Q1 EPS $3.87, consensus $2.16 02/18/21 Notable companies reporting before tomorrow's open DE Deere $381.47 / +2.69 (+0.71%) 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday 02/19/21 Fly Intel: Pre-market Movers 11/25/20 Fly Intel: Wall Street's top stories for Wednesday 04/15/21 FuboTV 04/16/21 Deere DE Deere $381.47 / +2.69 (+0.71%) 02/19/21 Early notable gainers among liquid option names on February 19th
Conference/Events	Acuity Brands management to meet virtually with Oppenheimer » 14:56 04/14/21 04/14 14:56 04/14/21 14:56 AYI Acuity Brands $170.61 / +0.51 (+0.30%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events AYI Acuity Brands $170.61 / +0.51 (+0.30%) 03/01/21 Acuity Brands appoints Trevor Palmer as president of Acuity Lighting 12/08/20 Acuity Brands publishes 2020 ESG report 11/19/20 Acuity Brands appoints Candace Steele Flippin as CCO 10/28/20 PURO Lighting announces strategic new alliance with Acuity Brands AYI Acuity Brands $170.61 / +0.51 (+0.30%) 04/05/21 Roth Capital Acuity Brands upgraded to Neutral from Sell at Roth Capital 04/05/21 Goldman Sachs Acuity Brands upgraded to Neutral from Sell at Goldman Sachs 04/01/21 Fly Intel: Top five analyst upgrades 04/01/21 Credit Suisse Acuity Brands price target raised to $186 from $152 at Credit Suisse AYI Acuity Brands $170.61 / +0.51 (+0.30%) 03/31/21 Acuity Brands reports Q2 adjusted EPS $2.12, consensus $1.73 03/30/21 Notable companies reporting before tomorrow's open 03/30/21 Notable companies reporting before tomorrow's open 01/07/21 Acuity Brands reports Q1 adjusted EPS $2.03, consensus $1.84 04/15/21 FuboTV
General news	Treasury Action: the bond market is unmoved by the Beige Book » 14:50 04/14/21 04/14 14:50 04/14/21 14:50 $ECON Economic Data / + Treasury Action: the bond… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><<
Options	Tanzanian Royalty options imply 65.9% move in share price post-earnings » 14:49 04/14/21 04/14 14:49 04/14/21 14:49 TRX Tanzanian Gold / + Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options TRX Tanzanian Gold / + 07:33 Today Tanzanian Gold to undergo review of exploration portfolio, strategy 07:30 Today Tanzanian Gold CEO says company positioned for "continued success" 03/01/21 Tanzanian Gold names Michael Leonard as CFO 02/25/21 Tanzanian Gold reports results from metallurgical test work at Buckreef Gold TRX Tanzanian Gold / + 02/16/21 Alliance Global Partners Tanzanian Gold initiated with a Buy at Alliance Global Partners TRX Tanzanian Gold / + 03/10/21 Largest borrow rate increases among liquid names 11/30/20 Tanzanian Royalty options imply 48.5% move in share price post-earnings
Options	AMMO call volume above normal and directionally bullish » 14:45 04/14/21 04/14 14:45 04/14/21 14:45 POWW AMMO $7.31 / -0.12 (-1.62%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options POWW AMMO $7.31 / -0.12 (-1.62%) 03/30/21 AMMO says LOI to acquire Gunbroker.com has extended by its own terms 03/23/21 AMMO initiates shipment of ammunition to EU Ally Nation 03/18/21 AMMO acquires new high precision ammunition loading line for Wisconsin plant 03/09/21 AMMO enters distribution agreement with BioAmmo POWW AMMO $7.31 / -0.12 (-1.62%) 04/08/21 Roth Capital AMMO initiated with a Buy at Roth Capital POWW AMMO $7.31 / -0.12 (-1.62%) 04/06/21 AMMO sees Q1 revenue in excess of $27M 04/01/21 AMMO reaffirms 2022 revenue view $120M 04/01/21 AMMO raises 2021 revenue view to $62M 04/01/21 AMMO raises Q4 revenue view to $24M from $20M 12 Mar 01 Dec POWW AMMO $7.31 / -0.12 (-1.62%) 03/12/21 Fly Intel: Wall Street's top stories for Friday 03/12/21 Fly Intel: Wall Street's top stories at midday 03/12/21 Fly Intel: Pre-market Movers 00:00 Today Emerging Growth Virtual Conference - 5 POWW AMMO $7.31 / -0.12 (-1.62%) 04/08/21 Unusually active option classes on open April 8th 03/02/21 Largest borrow rate increases among liquid names 02/11/21 Unusually active option classes on open February 11th 02/04/21 Unusually active option classes on open February 4th

Events

Earnings calls, analyst events, roadshows and more

Today at 15:45

Federal Reserve’s New Policy Framework Government Event

Virtual Event
AFMD
Today at 16:05

Affimed - AFMD Conference Calls
BRFH
Today at 16:30

Barfresh Food Group - BRFH Conference Calls
Today at 18:05

Fed Reserve Bank President Participates in Virtual Event Government Event

Virtual Event
GHG
Today at 21:00

GreenTree Hospitality - GHG Conference Calls
AKYA
Tomorrow at 00:00

Akoya Biosciences - AKYA Syndicate Roadshows

Virtual Meeting
BMEA
Tomorrow at 00:00

Biomea Fusion - BMEA Syndicate Roadshows

Virtual Meeting
COO
Tomorrow at 00:00

Cooper Companies - COO Conference Calls
VNRX
Tomorrow at 00:00

VolitionRx - VNRX Conference Calls
VERI
Tomorrow at 00:00

Veritone - VERI Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank Priced at: $33.95 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	DISCA X DISCA Discovery Block Trade Managers: Credit Suisse Priced at: $38.40 19M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DISCK X DISCK Discovery Inc. Block Trade Managers: Credit Suisse Priced at: $32.35 22M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IQ X IQ iQIYI Block Trade Managers: Credit Suisse Priced at: $15.85 35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham Priced at: $30.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	COIN X COIN Coinbase Direct Listing Managers: Direct Listing $250 Reference Price 114.851M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EBET X EBET Esports Technologies IPO Managers: Boustead $5.00-6.00 2M Shares KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BALY X BALY Bally's Secondary Managers: Deutsche Bank, Goldman Sachs & Barclays $60.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRZ X NRZ New Residential Secondary Managers: SBHS $10.94 45M Shares
Fri	No deals

View All Syndicate Announcements »

Barings BDC upgraded to Buy from Neutral at Compass Point

TODAY'S FREE FLY STORIES

Get Full Fly Access